Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06360133
PHASE3

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

Sponsor: VivaVision Biotech, Inc

View on ClinicalTrials.gov

Summary

This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.

Official title: A Phase 3, Randomized, Double-Masked, Vehicle-controlled, Multi-center Study Evaluating the Safety and Efficacy of 5% VVN001 in Chinese Subjects With Dry Eye Disease

Key Details

Gender

All

Age Range

30 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

700

Start Date

2024-04-01

Completion Date

2026-03-31

Last Updated

2024-11-20

Healthy Volunteers

No

Conditions

Interventions

DRUG

VVN001 Ophthalmic Solution, 5%

VVN001 Ophthalmic Solution, 5%

DRUG

VVN001 Ophthalmic Solution, Vehicle

VVN001 Ophthalmic Solution, Vehicle

Locations (1)

Eye & Ent Hospital of Fudan University

Shanghai, Shanghai Municipality, China